Navigation Links
Marco Romano, MD Joins Chiltern as Medical Director, Europe
Date:10/2/2007

LONDON, Oct. 3 /PRNewswire/ -- Chiltern, a leading global clinical research organization, has announced the appointment of Marco Romano, MD to the role of Medical Director, Europe. Dr. Romano has over 19 years of experience in both the Pharmaceutical and CRO Industries where he held executive-level positions, most recently with a large USA based CRO.

Dr. Romano earned his MD at the University of Genova, Italy, and he also holds a post-graduate degree in Hygiene, Epidemiology and Public Health from the University of Genova and a post-graduate degree in Clinical Pharmacology from the University of Milan. Dr Romano co-authored several scientific papers on mutagenesis and cancerogenesis, pharmacokinetics and pharmacodynamics of chemical compounds and glutathione metabolism.

Dr. Romano will be located in the company's Milan office. He will be responsible for the European medical department as well as heading one of our Global Therapeutic Area Teams. Dr. Romano will also focus on providing medical and scientific expertise to sponsors regarding product development and product life cycle management strategies. Dr Romano is closely connected to the Italian Pharmaceutical sector and will soon be President of SSFA, an influential medical association in Italy. His extensive experience and network will lead to the further development of our Italian operations.

"I am very pleased to join Chiltern," said Marco. "The global medical team is very strong and I look forward to working with them, our sponsors and our therapeutic focused teams."

"I am delighted that Marco has joined Chiltern," commented Lewis Cameron, Executive Vice President, Europe. "Marco's strong industry background and overall in-depth experience in clinical research will add to the dedicated medical and therapeutic teams already in place."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1000 people with 18 offices across the United States, Europe and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

For More Information Contact:

Catherine Lemercier

Chiltern International, Inc.

2111 Palomar Airport Road

Suite 200

Carlsbad

CA 92011

USA

Tel: 1 (760) 707 5025

Fax: 1 (760) 707 5022

Email: Catherine.Lemercier@chiltern.com

Richard Baptista

Chiltern International Ltd.

171 Bath Road

Slough

Berkshire

SL1 4AA

UNITED KINGDOM

Tel: 44 (0) 1753 512 000

Fax: 44 (0) 1753 511 116

Email: Richard.Baptista@chiltern.com

Chiltern: Understanding


'/>"/>
SOURCE Chiltern
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Check if your “Favourite medical web-site” is indulging in Quackey
10. Teens turning to Internet for medical queries
11. Robots craft medical history
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... has seen a significant spike in their clients' employee participation for their wellness ... health screening by implementing a high-deductible health plan with outcome-based deductible incentives. As ...
(Date:5/25/2016)... ... ... Stern Environmental Group , of Secaucus, New Jersey, working in conjunction ... Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first monitoring ... use in dormitories, shelters, and nursing homes for real time bedbug monitoring in May ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... (Rudy) Cifolelli has joined the company as Vice President of Sales. Cifolelli’s ... U.S. and international sales in the rapidly expanding field of organizational social engineering. ...
(Date:5/24/2016)... ... ... Jericho Project has named LaToya Williams-Belfort to the position of Chief Development and ... for the nationally-acclaimed nonprofit, working closely with CEO Tori Lyon and the Board of ... roots. , “LaToya Williams-Belfort is joining Jericho at an exciting time of growth ...
(Date:5/24/2016)... ... , ... How to Write Error Free Procedures, **Presented by Ginette M. Collazo ... is known to be the major cause of quality and production losses in many ... human performance problems can be prevented. , How to Write Error Free Procedures, part ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... India , May 25, 2016 ... Review, H1 2016"market research report that provides an ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:5/24/2016)... -- Diana Russell suffers from a form of rheumatoid arthritis ... This disease has put her in a wheelchair, and ... to leave her home.  Because of the size and ... wheelchair.  So if there is a family function, the ... to wait for the bus. Photo - ...
(Date:5/24/2016)... The innovator of COMBO ... s first dual therapy stent, introduces catheters for ... OrbusNeich, a global company specializing in the provision of ... products to treat peripheral artery disease. The JADE™ and ... for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology: